Inventor
Michael A. Gimbrone, Jr.
Inventor
Jamaica Plain, MA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes16%
A01KAnimal husbandry8%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
7,163,808'Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor'20076,759,210'Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target'20046,534,641'Compositions and methods for the treatment and diagnosis of cardiovascular disease'20036,492,126'Compositions and methods for the treatment and diagnosis of cardiovascular disease'20026,359,194'Compositions and methods for the treatment and diagnosis of cardiovascular disease'20026,225,084'Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target'20016,221,628'Compositions and methods for the treatment and diagnosis of cardiovascular disease using fchd540 as a target'20016,124,433'Compositions and methods for treatment and diagnosis of cardiovascular disease'20006,087,477'Compositions and methods for the treatment and diagnosis of cardiovascular disease'20006,054,558'Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target'20006,020,463'Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target'20006,018,025'Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target'20005,968,770'Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target'19995,708,147'Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis'19985,632,991'Antibodies specific for E-selectin and the uses thereof'19975,451,399'[ALA IL-8].sub.77 and [SER IL-8].sub.72 as Leukocyte adhesion inhibitors'19955,403,713'Antibodies specific for ELAM-1 and the use thereof'19955,302,384'Endothelial-derived II-8 adhesion inhibitor'19945,081,034'Cloned genes which encode ELAM-1'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2007Patents assigned to BRIGHAM & WOMENS HOSPITAL (17)· patent assignee history
1992Patents assigned to GEN HOSPITAL CORP (1)· patent assignee history
1992–2004Based in Jamaica Plain, MA, US· patent location history
1995Patents assigned to GENENTECH INC (1)· patent assignee history
1998Based in Boston, MA, US· patent location history
2000–2004Patents assigned to MILLENNIUM PHARM INC (10)· patent assignee history
2000Patents assigned to MILLENIUM PHARM INC (1)· patent assignee history
2007Based in Jamacia Plain, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRIGHAM & WOMENS HOSPITAL | 17 | 1992–2007 |
| MILLENNIUM PHARM INC | 10 | 2000–2004 |
| GEN HOSPITAL CORP | 1 | 1992 |
| GENENTECH INC | 1 | 1995 |
| MILLENIUM PHARM INC | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Jamaica Plain, Massachusetts, US | 17 | 1992–2004 |
| Jamacia Plain, Massachusetts, US | 1 | 2007 |
| Boston, Massachusetts, US | 1 | 1998 |